Mineralocorticoid receptor antagonists in dialysis patients after ACHIEVE and ALCHEMIST: updated systematic review and meta-analysis of 14 randomized trials. [PDF]
Zhu Y, Li J, Huang Z, Qiu F.
europepmc +1 more source
ABSTRACT Atrial fibrillation (AF) is closely associated with comorbidities and lifestyle factors that influence the development, progression, and outcomes. Here the focus is on guidelines for the systematic management of hypertension, heart failure, coronary and structural heart disease, diabetes, dyslipidemia, cerebrovascular disease, obesity, chronic
Eue‐Keun Choi +16 more
wiley +1 more source
Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome. [PDF]
Navaneethan SD +3 more
europepmc +1 more source
Cardiorenal Effects of Switching from Eplerenone to Esaxerenone in Patients with Chronic Heart Failure and Hypertension: A Prospective Clinical Study. [PDF]
Sezai A +5 more
europepmc +1 more source
Bilateral giant myelolipomas in a female patient with untreated 21-hydroxylase deficiency. [PDF]
Welp AC +5 more
europepmc +1 more source
Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study. [PDF]
Wu JY +4 more
europepmc +1 more source
Related searches:
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
European Heart Journal, 2021Faiez Zannad +2 more
exaly
Mineralocorticoid pathway in retinal health and diseases
British Journal of Pharmacology, 2022Francine Béhar-Cohen, Min Zhao
exaly

